# Natural History Study: ENPP1 Deficiency or the Early-Onset Form of ABCC6 Deficiency

> **NCT07745179** · — · COMPLETED · sponsor: **Inozyme Pharma** · enrollment: 23 (actual)

## Conditions studied

- Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
- ATP-Binding Cassette Subfamily C Member 6 Deficiency
- Generalized Arterial Calcification of Infancy
- Autosomal Recessive Hypophosphatemic Rickets
- PXE (Pseudoxanthoma Elasticum)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07745179
- **Lead sponsor:** Inozyme Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-05
- **Primary completion:** 2023-06-08
- **Final completion:** 2025-02-14
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2026-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07745179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07745179, "Natural History Study: ENPP1 Deficiency or the Early-Onset Form of ABCC6 Deficiency". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07745179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*